(Bloomberg) -- Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The ...

In the wake of Eight Capital’s closure, approximately a dozen employees from the firm’s sales and trading division, as well as its mining advisory practice, are expected to transition to Stifel Canada ...

Stifel analyst Benjamin Nolan upgraded CN (CNI) to Buy from Hold with a lower price target of $120, down from $132, as part of a broader research note previewing Q4 results for Rail companies. The ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The partnership at ...

Roughly a dozen employees from Eight’s sales and trading arm, as well as its mining advisory practice, are expected to join Stifel Canada, three of the sources said. They include top producers ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If you’re on the fence about investing in Raymond James Financial, Inc. or Stifel Financial Corp. because you’re not sure how they measure up, it’s important to compare them on a few factors before ...

On Wednesday, Stifel reiterated its favorable stance on Celldex Therapeutics (NASDAQ:CLDX) and Third Harmonic (NASDAQ:HLIT) Bio (NASDAQ:THRD), highlighting their potential as leaders in the mast ...

Analysts at Stifel and BMO Capital Markets cut the stock rating of Paycor (NASDAQ:PYCR) HCM, in response to Paychex's (NASDAQ:PAYX) move to acquire the company for $22.50 per share. This ...

Stifel analyst Annabel Samimy initiated coverage of Altimmune (ALT) with a Buy rating and $18 price target The company is developing next-generation peptide-based therapeutics with a novel GLP-1 ...